Sobi boosts gout battle with Arthrosi Therapeutics acquisition
Immune ‘switch’ is potential target to curb chronic inflammation in cirrhosis
InnoCare to move to phase 3 after achieving SLE endpoints
First precision therapy prostate cancer drug approved
EIC Accelerator: strong performance of engineering and tech-based companies
Ibex raises $55m to drive global adoption of AI for cancer diagnosis
Valhalla Ventures launches $66M fund to back deeptech innovators